This study determines the relative cost-effectiveness of food and cash transfers when administered to Human Immuno-deficiency Virus (HIV) / Acquired Immune-Deficiency Syndrome (AIDS) patients on Anti-Retroviral Therapy (ART) in Zambia. The results show that cash transfers are not only cheaper but also unambiguously more cost-effective with respect to nutrition and health outcomes such as body-mass index (BMI) and Cluster of Differentiation 4 (CD4) count. This seems to suggest that, whenever market conditions and institutional capacities (banks, personnel, etc.) permit, cash should be given a higher rating by governments and other programming stakeholders than physical food aid as an instrument for influencing health and nutrition outcomes among HIV patients that are on ART.
Mwansakilwa, Chibamba and Tembo, Gelson
"Cost-Effectiveness of Food and Cash Transfers to Patients under Anti-Retroviral Treatment in Zambia,"
Southern African Journal of Policy and Development: Vol. 1
, Article 5.
Available at: https://scholarship.law.cornell.edu/sajpd/vol1/iss1/5